| Identification of urinary exosomal noncoding RNAs as novel biomarkers in chronic kidney disease R Khurana, G Ranches, S Schafferer, M Lukasser, M Rudnicki, G Mayer, ... Rna 23 (2), 142-152, 2017 | 155 | 2017 |
| The clinical kinase index: a method to prioritize understudied kinases as drug targets for the treatment of cancer D Essegian, R Khurana, V Stathias, SC Schürer Cell Reports Medicine 1 (7), 2020 | 58 | 2020 |
| Changes in the miRNA-mRNA regulatory network precede motor symptoms in a mouse model of multiple system atrophy: clinical implications S Schafferer, R Khurana, V Refolo, S Venezia, E Sturm, P Piatti, ... PLoS One 11 (3), e0150705, 2016 | 29 | 2016 |
| Reversal of lactate and PD-1–mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer K Chaudagar, HM Hieromnimon, R Khurana, B Labadie, T Hirz, S Mei, ... Clinical Cancer Research 29 (10), 1952-1968, 2023 | 27 | 2023 |
| OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer R Khurana, VK Verma, A Rawoof, S Tiwari, RA Nair, G Mahidhara, ... BMC bioinformatics 15, 1-12, 2014 | 23 | 2014 |
| A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer S Khalafi, S Zhu, R Khurana, I Lohse, S Giordano, S Corso, H Al-Ali, ... Translational oncology 15 (1), 101260, 2022 | 6 | 2022 |
| Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures Z Jiang, C Cinti, M Taranta, E Mattioli, E Schena, S Singh, R Khurana, ... Plos one 13 (11), e0206686, 2018 | 4 | 2018 |
| The Clinical Kinase Index: Prioritizing Understudied Kinases as Targets for the Treatment of Cancer D Essegian, R Khurana, V Stathias, S Schürer Available at SSRN 3489452, 2019 | 3 | 2019 |
| The Clinical Kinase Index (CKI): A user friendly application to prioritize kinases as prospective cancer drug targets R Khurana, SC Schürer Software Impacts 12, 100257, 2022 | 1 | 2022 |
| Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t (11; 14) S Chaudhry, N Nguyen, R Khurana, TM Totiger, S Montoya, J Afaghani, ... Cancer Research 82 (12_Supplement), 4067-4067, 2022 | | 2022 |
| The dark cancer kinome-untapped opportunities for the development of novel drugs DJ Essegian, R Khurana, V Stathias, V Chavez, JR Merchan, S Schürer Cancer Research 79 (13_Supplement), 5103-5103, 2019 | | 2019 |
Hubert HacklMedical University of Innsbruck在 i-med.ac.at 的电子邮件经过验证
